Pro-Apoptotic Role of the Human YPEL5 Gene Identified By

Total Page:16

File Type:pdf, Size:1020Kb

Pro-Apoptotic Role of the Human YPEL5 Gene Identified By J. Microbiol. Biotechnol. (2017), 27(3), 633–643 https://doi.org/10.4014/jmb.1610.10045 Research Article Review jmb Pro-Apoptotic Role of the Human YPEL5 Gene Identified by Functional Complementation of a Yeast moh1Δ Mutation Ji Young Lee1, Do Youn Jun1, Ju Eun Park1, Gi Hyun Kwon1, Jong-Sik Kim2, and Young Ho Kim1* 1Laboratory of Immunobiology, School of Life Science and Biotechnology, College of Natural Sciences, Kyungpook National University, Daegu 41566, Republic of Korea 2Department of Biological Sciences, Andong National University, Andong 36729, Republic of Korea Received: October 18, 2016 Revised: February 4, 2017 To examine the pro-apoptotic role of the human ortholog (YPEL5) of the Drosophila Yippee Accepted: February 6, 2017 protein, the cell viability of Saccharomyces cerevisiae mutant strain with deleted MOH1, the yeast ortholog, was compared with that of the wild-type (WT)-MOH1 strain after exposure to different apoptogenic stimulants, including UV irradiation, methyl methanesulfonate (MMS), First published online camptothecin (CPT), heat shock, and hyperosmotic shock. The moh1Δ mutant exhibited February 7, 2017 enhanced cell viability compared with the WT-MOH1 strain when treated with lethal UV *Corresponding author irradiation, 1.8 mM MMS, 100 μM CPT, heat shock at 50°C, or 1.2 M KCl. At the same time, the Phone: +82-53-950-5378; level of Moh1 protein was commonly up-regulated in the WT-MOH1 strain as was that of Fax: +82-53-955-5522; Ynk1 protein, which is known as a marker for DNA damage. Although the enhanced UV E-mail: [email protected] resistance of the moh1Δ mutant largely disappeared following transformation with the yeast MOH1 gene or one of the human YPEL1-YPEL5 genes, the transformant bearing pYES2- YPEL5 was more sensitive to lethal UV irradiation and its UV sensitivity was similar to that of the WT-MOH1 strain. Under these conditions, the UV irradiation-induced apoptotic events, such as FITC-Annexin V stainability, mitochondrial membrane potential (Δψm) loss, and metacaspase activation, occurred to a much lesser extent in the moh1Δ mutant compared with the WT-MOH1 strain and the mutant strain bearing pYES2-MOH1 or pYES2-YPEL5. These results demonstrate the functional conservation between yeast Moh1 and human YPEL5, and their involvement in mitochondria-dependent apoptosis induced by DNA damage. pISSN 1017-7825, eISSN 1738-8872 Copyright© 2017 by Keywords: Apoptosis, DNA damage, Drosophila Yippee, human YPEL5, metacaspase, S. cerevisiae The Korean Society for Microbiology MOH1 and Biotechnology Introduction YPEL family members and Drosophila Yippee, human YPEL1-YPEL4 shows 43.4-45.5% identity with Drosophila The Drosophila Yippee protein was initially identified, Yippee, and human YPEL5 shows 70.8% identity, indicating using the yeast two-hybrid method, as an intracellular YPEL5 among the human YPEL family members is the protein that interacts with a blood protein (hemoline) from most closely aligned with the Drosophila Yippee protein. the moth Hyalophora cecropia [1]. Since then, orthologs of Semiquantitative polymerase chain reaction revealed that the Drosophila Yippee protein have been found in a wide transcripts for YPEL3 and YPEL5 were ubiquitously range of eukaryotes, from yeast to human. During expressed in human tissues; however, those for YPEL1, comprehensive human chromosome sequence analysis, a YPEL2, and YPEL4 exhibited more restrictive expression novel gene family consisting of five members (YPEL1 patterns [2]. Immunofluorescence staining of African green through YPEL5) possessing a high homology with the monkey kidney fibroblast COS-7 cells showed that Ypel5 is Drosophila Yippee gene was identified [2]. Based on localized in the nucleus and centrosome at interphase, comparison of the overall amino acid sequences of human whereas it relocates to the spindle pole, mitotic spindle, March 2017 ⎪ Vol. 27⎪ No. 3 634 Lee et al. and midbody during the M phase [2, 3]. Interestingly, constructed by deletion of the MOH1 gene, and the WT- human YPEL3, which was described as a small unstable MOH1 strain to compare their cytotoxic sensitivity to apoptotic protein in murine myeloid cells [4], has been different apoptogenic stimulants such as UV irradiation, reported to be involved in growth suppression, causing DNA-damaging drug, heat shock, and hyperosmotic shock. cellular senescence in human cell lines, and its expression is Additionally, we have examined whether transformation regulated by the tumor suppressor protein p53, with lower of the moh1Δ mutant with recombinant plasmids bearing expression in several human tumors [5-7]. the MOH1 gene or one of the YPEL family genes can These previous observations raised the possibility that abrogate the elevated resistance of the mutant strain human YPEL family proteins play an important role in the against lethal UV irradiation, due to their pro-apoptotic regulation of cell division and/or apoptosis; however, this contribution to the mitochondrial apoptotic pathway. prediction remains to be elucidated. Furthermore, it is uncertain whether the intracellular function of YPEL family Materials and Methods proteins, which was predicted in the human orthologs, can be extended to other eukaryotic species, including yeasts. Reagents, Kits, Antibodies, Cells, and Media The budding yeast Saccharomyces cerevisiae ortholog MOH1 The camptothecin (CPT) and the DNA alkylating agent methyl gene was identified as a gene (YBL049W) possessing methanesulfonate (MMS) were purchased from Sigma-Aldrich sequence similarity to the Drosophila Yippee gene when (USA). An ECL western blot kit was purchased from GE Healthcare sequencing and functional analysis were performed for a Life Sciences (UK). The FITC-Annexin V apoptosis detection kit and JC-1 (5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethylbenzimidazolocarbocyanine 32,560 bp segment of the left arm of S. cerevisiae chromosome iodide) were purchased from Invitrogen (USA). Anti-Ynk1 (anti- II [1, 8]. Although analysis of the phenotype of S. cerevisiae NM23-H1) was purchased from Santa Cruz Biotechnology (USA), deletion mutants can be an efficient approach for studying and anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene function [9-11], there have been no reports on antibody was purchased from Thermo Scientific (USA). Rat phenotypic analysis of the mutant strain to determine antisera raised against either recombinant human YPEL5 protein MOH1 gene function. Furthermore, S. cerevisiae is a good or recombinant S. cerevisiae Moh1 protein, both of which were eukaryotic model organism for the study of many expressed as GST-fusion forms using an Escherichia coli system, fundamental biological processes, such as apoptotic cell were prepared essentially as described previously [15]. These rat death, cell cycle regulation, and DNA repair, which occur polyclonal anti-YPEL5 and anti-Moh1 antibodies were able to commonly in eukaryotic cells [12, 13]. In these contexts, we react with human YPEL5 and yeast Moh1, respectively. have decided to compare the phenotype of the moh1Δ Wild-type (WT)-MOH1 S. cerevisiae BY4741 (MATa, his3∆1, mutant strain with that of the wild-type (WT)-MOH1 leu2∆0, met15∆0, ura3∆0) and the MOH1-deletion mutant derived from S. cerevisiae BY4741 were obtained from ATCC (USA). The strain, and to determine whether the mutant phenotype WT-MOH1 strain and the moh1Δ mutant strain were cultured in can be recovered to the WT levels by complementation YPD medium containing 2% dextrose, 2% peptone, 1% yeast using plasmids expressing the human YPEL family genes. extract, and 200 μg/ml G418. The yeast strains overexpressing In a previous study, we found the human YPEL5 gene to Moh1 or YPEL1-YPEL5 were constructed by transformation of be an interesting gene, in that its mRNA expression was the yeast moh1Δ mutant with recombinant plasmid pYES2-MOH1 easily detectable in unstimulated human peripheral T cells or pYES2-YPEL1-pYES2-YPEL5. Both the WT-MOH1 strain and and then rapidly declined to undetectable level by 5 h moh1Δ mutant were transformed with empty vector plasmid following immobilized anti-CD3 activation [14]. Additionally, pYES2 and used as controls. Since the expression vector pYES2 we observed that ectopic overexpression of the YPEL5 gene contains the URA3 gene, individual transformants were selected in human cervical carcinoma HeLa cells caused a significant on synthetic complete galactose (SC-gal) solid medium (2% reduction in cell proliferation to the level of 47% of the galactose, 0.67% yeast nitrogen base w/o amino acid, 0.01% control, suggesting that YPEL5 might exert a suppressive leucine, 0.005% methionine, 0.005% histidine, 200 μg/ml G418, and 1.8% agar). effect on cell proliferation. However, the possible role of YPEL5 in induction of apoptosis, which led to the anti- Treatment Conditions for UV Irradiation, DNA-Damaging proliferative activity, and underlying cellular and molecular Drug, Heat Shock, and Hyperosmotic Shock, and Cell Viability mechanism remain to be elucidated. Assays As an attempt to obtain direct evidence for a pro-apoptotic To compare the sensitivity of the WT-MOH1 strain and the role of human YPEL5, in the present study, we have MOH1-deletion mutant with various cytotoxic factors, the cells employed a budding yeast S. cerevisiae mutant strain, grown in YPD medium at log phase were suspended in fresh YPD J. Microbiol. Biotechnol. Apoptotic Activity of Yeast Moh1 and Human YPEL5 635 medium (A600 = 0.4). Five microliters of 3-fold serial dilutions of AGTACATTTAC-3’) were used for the PCR.
Recommended publications
  • Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model
    Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 T + is online at: average * The Journal of Immunology , 34 of which you can access for free at: 2016; 197:1477-1488; Prepublished online 1 July from submission to initial decision 4 weeks from acceptance to publication 2016; doi: 10.4049/jimmunol.1600589 http://www.jimmunol.org/content/197/4/1477 Molecular Profile of Tumor-Specific CD8 Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A. Waugh, Sonia M. Leach, Brandon L. Moore, Tullia C. Bruno, Jonathan D. Buhrman and Jill E. Slansky J Immunol cites 95 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2016/07/01/jimmunol.160058 9.DCSupplemental This article http://www.jimmunol.org/content/197/4/1477.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 25, 2021. The Journal of Immunology Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A.
    [Show full text]
  • Large Meta-Analysis of Genome-Wide Association Studies
    medRxiv preprint doi: https://doi.org/10.1101/2020.10.01.20200659; this version posted October 4, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Large meta-analysis of genome-wide association studies expands knowledge of the genetic etiology of Alzheimer’s disease and highlights potential translational opportunities Céline Bellenguez1,*,#, Fahri Küçükali2,3,4*, Iris Jansen5,6*, Victor Andrade7,8*, Sonia Morenau- Grau9,10,*, Najaf Amin11,12, Benjamin Grenier-Boley1, Anne Boland13, Luca Kleineidam7,8, Peter Holmans14, Pablo Garcia9,10, Rafael Campos Martin7, Adam Naj15,16, Yang Qiong17, Joshua C. Bis18, Vincent Damotte1, Sven Van der Lee5,6,19, Marcos Costa1, Julien Chapuis1, Vilmentas Giedraitis20, María Jesús Bullido10,21, Adolfo López de Munáin10,22, Jordi Pérez- Tur10,23, Pascual Sánchez-Juan10,24, Raquel Sánchez-Valle25, Victoria Álvarez26, Pau Pastor27, Miguel Medina10,28, Jasper Van Dongen2,3,4, Christine Van Broeckhoven2,3,4, Rik Vandenberghe29,30, Sebastiaan Engelborghs31,32, Gael Nicolas33, Florence Pasquier34, Olivier Hanon35, Carole Dufouil36, Claudine Berr37, Stéphanie Debette36, Jean-François Dartigues36, Gianfranco Spalletta38, Benedetta Nacmias39,40, Vincenzo Solfrezzi41, Barbara Borroni42, Lucio Tremolizzo43, Davide Seripa44, Paolo Caffarra45, Antonio Daniele46,47, Daniela Galimberti48,49, Innocenzo Rainero50, Luisa Benussi51, Alesio Squassina52, Patrizia Mecoci53, Lucilla Parnetti54, Carlo Masullo55, Beatrice Arosio56, John Hardy57, Simon Mead58, Kevin Morgan59, Clive Holmes60, Patrick Kehoe61, Bob Woods62, EADB, Charge, ADGC, Jin Sha15,16, Yi Zhao15,63, Chien-Yueh Lee15,63, Pavel P.
    [Show full text]
  • NATURAL KILLER CELLS, HYPOXIA, and EPIGENETIC REGULATION of HEMOCHORIAL PLACENTATION by Damayanti Chakraborty Submitted to the G
    NATURAL KILLER CELLS, HYPOXIA, AND EPIGENETIC REGULATION OF HEMOCHORIAL PLACENTATION BY Damayanti Chakraborty Submitted to the graduate degree program in Pathology and Laboratory Medicine and the Graduate Faculty of the University of Kansas in partial fulfillment ofthe requirements for the degree of Doctor of Philosophy. ________________________________ Chair: Michael J. Soares, Ph.D. ________________________________ Jay Vivian, Ph.D. ________________________________ Patrick Fields, Ph.D. ________________________________ Soumen Paul, Ph.D. ________________________________ Michael Wolfe, Ph.D. ________________________________ Adam J. Krieg, Ph.D. Date Defended: 04/01/2013 The Dissertation Committee for Damayanti Chakraborty certifies that this is the approved version of the following dissertation: NATURAL KILLER CELLS, HYPOXIA, AND EPIGENETIC REGULATION OF HEMOCHORIAL PLACENTATION ________________________________ Chair: Michael J. Soares, Ph.D. Date approved: 04/01/2013 ii ABSTRACT During the establishment of pregnancy, uterine stromal cells differentiate into decidual cells and recruit natural killer (NK) cells. These NK cells are characterized by low cytotoxicity and distinct cytokine production. In rodent as well as in human pregnancy, the uterine NK cells peak in number around mid-gestation after which they decline. NK cells associate with uterine spiral arteries and are implicated in pregnancy associated vascular remodeling processes and potentially in modulating trophoblast invasion. Failure of trophoblast invasion and vascular remodeling has been shown to be associated with pathological conditions like preeclampsia syndrome, hypertension in mother and/or fetal growth restriction. We hypothesize that NK cells fundamentally contribute to the organization of the placentation site. In order to study the in vivo role of NK cells during pregnancy, gestation stage- specific NK cell depletion was performed in rats using anti asialo GM1 antibodies.
    [Show full text]
  • Associated 16P11.2 Deletion in Drosophila Melanogaster
    ARTICLE DOI: 10.1038/s41467-018-04882-6 OPEN Pervasive genetic interactions modulate neurodevelopmental defects of the autism- associated 16p11.2 deletion in Drosophila melanogaster Janani Iyer1, Mayanglambam Dhruba Singh1, Matthew Jensen1,2, Payal Patel 1, Lucilla Pizzo1, Emily Huber1, Haley Koerselman3, Alexis T. Weiner 1, Paola Lepanto4, Komal Vadodaria1, Alexis Kubina1, Qingyu Wang 1,2, Abigail Talbert1, Sneha Yennawar1, Jose Badano 4, J. Robert Manak3,5, Melissa M. Rolls1, Arjun Krishnan6,7 & 1234567890():,; Santhosh Girirajan 1,2,8 As opposed to syndromic CNVs caused by single genes, extensive phenotypic heterogeneity in variably-expressive CNVs complicates disease gene discovery and functional evaluation. Here, we propose a complex interaction model for pathogenicity of the autism-associated 16p11.2 deletion, where CNV genes interact with each other in conserved pathways to modulate expression of the phenotype. Using multiple quantitative methods in Drosophila RNAi lines, we identify a range of neurodevelopmental phenotypes for knockdown of indi- vidual 16p11.2 homologs in different tissues. We test 565 pairwise knockdowns in the developing eye, and identify 24 interactions between pairs of 16p11.2 homologs and 46 interactions between 16p11.2 homologs and neurodevelopmental genes that suppress or enhance cell proliferation phenotypes compared to one-hit knockdowns. These interac- tions within cell proliferation pathways are also enriched in a human brain-specific network, providing translational relevance in humans. Our study indicates a role for pervasive genetic interactions within CNVs towards cellular and developmental phenotypes. 1 Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA 16802, USA. 2 Bioinformatics and Genomics Program, The Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park, PA 16802, USA.
    [Show full text]
  • Genome-Wide Profiling of Promoter Methylation in Human
    Oncogene (2006) 25, 3059–3064 & 2006 Nature Publishing Group All rights reserved 0950-9232/06 $30.00 www.nature.com/onc TECHNICAL REPORT Genome-wide profiling of promoter methylation in human I Hatada1,2, M Fukasawa1,2, M Kimura1,2, S Morita1,2, K Yamada3, T Yoshikawa3, S Yamanaka4,5, C Endo4, A Sakurada4, M Sato4, T Kondo4, A Horii5, T Ushijima6 and H Sasaki7,8 1Laboratory of Genome Science, Biosignal Genome Resource Center, Department of Molecular and Cellular Biology, Gunma University, Maebashi, Japan; 2PRESTO, Japan Science and Technology Corporation (JST), Kawaguchi, Japan; 3Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Wako, Japan, 4Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan; 5Department of Molecular Pathology, Tohoku University School of Medicine, Sendai, Japan; 6Carcinogenesis Division, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan; 7Division of Human Genetics, Department of Integrated Genetics, National Institute of Genetics, Research Organization of Information and Systems, Mishima, Japan and 8Department of Genetics, School of Life Science, Graduate University for Advanced Studies, Mishima, Japan DNA methylation in the promoter region of a gene is Microarray-based methods of comparing differences in associated with a loss of that gene’s expression and plays DNA methylation in the genome of two samples using an important role in gene silencing. The inactivation of methylation-sensitive restriction enzymes (Yan et al., tumor-suppressor genes by aberrant methylation in the 2001; Hatada et al., 2002) have two problems. The first promoter region is well recognized in carcinogenesis. is that the microarrays contain clones from libraries of However, there has been little study in this area when it CpG islands.
    [Show full text]
  • YPEL3, a P53-Regulated Gene That Induces Cellular Senescence
    Published OnlineFirst April 13, 2010; DOI: 10.1158/0008-5472.CAN-09-3219 Molecular and Cellular Pathobiology Cancer Research YPEL3, a p53-Regulated Gene that Induces Cellular Senescence Kevin D. Kelley1, Kelly R. Miller1, Amber Todd1, Amy R. Kelley1, Rebecca Tuttle2, and Steven J. Berberich1 Abstract Cellular senescence, the limited ability of cultured normal cells to divide, can result from cellular damage triggered through oncogene activation (premature senescence) or the loss of telomeres following successive rounds of DNA replication (replicative senescence). Although both processes require a functional p53 signaling pathway, relevant downstream p53 targets have been difficult to identify. Discovery of senescence activators is important because induction of tumor cell senescence may represent a therapeutic approach for the treat- ment of cancer. In microarray studies in which p53 was reactivated in MCF7 cells, we discovered that Yippee- like-3 (YPEL3), a member of a recently discovered family of putative zinc finger motif coding genes consisting of YPEL1-5, is a p53-regulated gene. YPEL3 expression induced by DNA damage leads to p53 recruitment to a cis-acting DNA response element located near the human YPEL3 promoter. Physiologic induction of YPEL3 results in a substantial decrease in cell viability associated with an increase in cellular senescence. Through the use of RNAi and H-ras induction of cellular senescence, we show that YPEL3 activates cellular senescence downstream of p53. Consistent with its growth suppressive activity, YPEL3 gene expression is repressed in ovarian tumor samples. One mechanism of YPEL3 downregulation in ovarian tumor cell lines seems to be hypermethylation of a CpG island upstream of the YPEL3 promoter.
    [Show full text]
  • YPEL3 Antibody Cat
    YPEL3 Antibody Cat. No.: 6775 Western blot analysis of YPEL3 in A-20 cell lysate with YPEL3 antibody at 1 μg/mL in (A) the absence and (B) the presence of blocking peptide Immunocytochemistry of YPEL3 in A20 cells with YPEL3 Immunofluorescence of YPEL3 in A20 cells with YPEL3 antibody at 2.5 μg/mL. antibody at 5 μg/mL. Specifications HOST SPECIES: Rabbit SPECIES REACTIVITY: Human, Mouse, Rat HOMOLOGY: Predicted species reactivity based on immunogen sequence: Bovine: (100%) YPEL3 antibody was raised against a 15 amino acid synthetic peptide near the amino terminus of human YPEL3. IMMUNOGEN: The immunogen is located within amino acids 20 - 70 of YPEL3. TESTED APPLICATIONS: ELISA, ICC, IF, WB September 28, 2021 1 https://www.prosci-inc.com/ypel3-antibody-6775.html YPEL3 antibody can be used for detection of YPEL3 by Western blot at 1 μg/mL. Antibody can also be used for immunocytochemistry starting at 2.5 μg/mL. For immunofluorescence start at 2.5 μg/mL. APPLICATIONS: Antibody validated: Western Blot in mouse samples; Immunocytochemistry in mouse samples and Immunofluorescence in mouse samples. All other applications and species not yet tested. POSITIVE CONTROL: 1) Cat. No. 1288 - A20 Cell Lysate 2) Cat. No. 17-208 - A-20 Cell Slide Properties PURIFICATION: YPEL3 Antibody is affinity chromatography purified via peptide column. CLONALITY: Polyclonal ISOTYPE: IgG CONJUGATE: Unconjugated PHYSICAL STATE: Liquid BUFFER: YPEL3 Antibody is supplied in PBS containing 0.02% sodium azide. CONCENTRATION: 1 mg/mL YPEL3 antibody can be stored at 4˚C for three months and -20˚C, stable for up to one STORAGE CONDITIONS: year.
    [Show full text]
  • Mammalian Atypical E2fs Link Endocycle Control to Cancer
    Mammalian Atypical E2Fs Link Endocycle Control to Cancer DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Hui-Zi Chen Graduate Program in Integrated Biomedical Science Program The Ohio State University 2011 Dissertation Committee: Gustavo Leone, PhD, Advisor Michael Ostrowski, PhD Clay Marsh, MD Tsonwin Hai, PhD Kathryn Wikenheiser-Brokamp, MD PhD Copyright by Hui-Zi Chen 2011 Abstract The endocycle is a developmentally programmed variant cell cycle consisting of successive S (DNA synthesis) and G (Gap) phases without an intervening M phase or cytokinesis. As a consequence of the regulated “decoupling” of DNA replication and mitosis, which are two central processes of the traditional cell division program, endocycling cells acquire highly polyploid genomes after having undergone multiple rounds of whole genome reduplication. Although essential for metazoan development, relatively little is known about the regulation of endocycle or its physiologic role in higher vertebrates such as the mammal. A substantial body of work in the model organism Drosophila melanogaster has demonstrated an important function for dE2Fs in the control of endocycle. Genetic studies showed that both endocycle initiation and progression is severely disrupted by altering the expression of the fly E2F activator (dE2F1) or repressor (dE2F2). In mammals, the E2F family is comprised of nine structurally related proteins, encoded by eight distinct genes, that can be classified into transcriptional activators (E2f1, E2f2, E2f3a and E2f3b) or repressors (E2f4, E2f5, E2f6, E2f7 and E2f8). The repressor subclass may then be further divided into canonical (E2f4, E2f5 and E2f6) or atypical E2fs (E2f7 and E2f8).
    [Show full text]
  • A High Throughput, Functional Screen of Human Body Mass Index GWAS Loci Using Tissue-Specific Rnai Drosophila Melanogaster Crosses Thomas J
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2018 A high throughput, functional screen of human Body Mass Index GWAS loci using tissue-specific RNAi Drosophila melanogaster crosses Thomas J. Baranski Washington University School of Medicine in St. Louis Aldi T. Kraja Washington University School of Medicine in St. Louis Jill L. Fink Washington University School of Medicine in St. Louis Mary Feitosa Washington University School of Medicine in St. Louis Petra A. Lenzini Washington University School of Medicine in St. Louis See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Recommended Citation Baranski, Thomas J.; Kraja, Aldi T.; Fink, Jill L.; Feitosa, Mary; Lenzini, Petra A.; Borecki, Ingrid B.; Liu, Ching-Ti; Cupples, L. Adrienne; North, Kari E.; and Province, Michael A., ,"A high throughput, functional screen of human Body Mass Index GWAS loci using tissue-specific RNAi Drosophila melanogaster crosses." PLoS Genetics.14,4. e1007222. (2018). https://digitalcommons.wustl.edu/open_access_pubs/6820 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Authors Thomas J. Baranski, Aldi T. Kraja, Jill L. Fink, Mary Feitosa, Petra A. Lenzini, Ingrid B. Borecki, Ching-Ti Liu, L. Adrienne Cupples, Kari E. North, and Michael A. Province This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/open_access_pubs/6820 RESEARCH ARTICLE A high throughput, functional screen of human Body Mass Index GWAS loci using tissue-specific RNAi Drosophila melanogaster crosses Thomas J.
    [Show full text]
  • Robles JTO Supplemental Digital Content 1
    Supplementary Materials An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma based on mRNA, microRNA and DNA Methylation Biomarkers Ana I. Robles1, Eri Arai2, Ewy A. Mathé1, Hirokazu Okayama1, Aaron Schetter1, Derek Brown1, David Petersen3, Elise D. Bowman1, Rintaro Noro1, Judith A. Welsh1, Daniel C. Edelman3, Holly S. Stevenson3, Yonghong Wang3, Naoto Tsuchiya4, Takashi Kohno4, Vidar Skaug5, Steen Mollerup5, Aage Haugen5, Paul S. Meltzer3, Jun Yokota6, Yae Kanai2 and Curtis C. Harris1 Affiliations: 1Laboratory of Human Carcinogenesis, NCI-CCR, National Institutes of Health, Bethesda, MD 20892, USA. 2Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo 104-0045, Japan. 3Genetics Branch, NCI-CCR, National Institutes of Health, Bethesda, MD 20892, USA. 4Division of Genome Biology, National Cancer Center Research Institute, Tokyo 104-0045, Japan. 5Department of Chemical and Biological Working Environment, National Institute of Occupational Health, NO-0033 Oslo, Norway. 6Genomics and Epigenomics of Cancer Prediction Program, Institute of Predictive and Personalized Medicine of Cancer (IMPPC), 08916 Badalona (Barcelona), Spain. List of Supplementary Materials Supplementary Materials and Methods Fig. S1. Hierarchical clustering of based on CpG sites differentially-methylated in Stage I ADC compared to non-tumor adjacent tissues. Fig. S2. Confirmatory pyrosequencing analysis of DNA methylation at the HOXA9 locus in Stage I ADC from a subset of the NCI microarray cohort. 1 Fig. S3. Methylation Beta-values for HOXA9 probe cg26521404 in Stage I ADC samples from Japan. Fig. S4. Kaplan-Meier analysis of HOXA9 promoter methylation in a published cohort of Stage I lung ADC (J Clin Oncol 2013;31(32):4140-7). Fig. S5. Kaplan-Meier analysis of a combined prognostic biomarker in Stage I lung ADC.
    [Show full text]
  • Gene Section Short Communication
    Atlas of Genetics and Cytogenetics in Oncology and Haematology INIST -CNRS OPEN ACCESS JOURNAL Gene Section Short Communication YPEL3 (yippee-like 3 (Drosophila)) Gizem Güpür, Mesut Muyan Department of Biological Sciences, Middle East Technical University, Ankara, Turkey (GG, MM) Published in Atlas Database: April 2014 Online updated version : http://AtlasGeneticsOncology.org/Genes/YPEL3ID51528ch16p11.html DOI: 10.4267/2042/55376 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 2015 Atlas of Genetics and Cytogenetics in Oncology and Haematology Abstract DNA/RNA Short communication on YPEL3, with data on Description DNA/RNA, on the protein encoded and where the YPEL3 has 4 exons. gene is implicated. Transcription Identity YPEL3 has 2 transcript variants, resulting from the HGNC (Hugo): YPEL3 differential processing of the exon 1. Transcript variant 1: 1588 bp mRNA (NCBI Location: 16p11.2 RefSeq NM_031477.4). Local order: From telomere to centromere: Transcript variant 2: 940 bp mRNA (NCBI RefSeq MAPK3-GDPD3-LOC101928595-YPEL3 -TBX6- NM_001145524.1). PPP4C-ALDOA-FAM57B-C16orf92-DOC2A. Local order of YPEL3 is shown together with leading and subsequent genes on chromosome 16. Boxes show exons; filled boxes correspond to coding exons, empty boxes indicate noncoding exons. Lines connecting the boxes represent introns. Arrows indicate the translation initiation codon. Atlas Genet Cytogenet Oncol Haematol. 2014; 19(1) 38 YPEL3 (yippee-like 3 (Drosophila)) Güpür G, Muyan M Protein follows: C-X2-C-X19 -G-X3-L-X5-N-X13 -G-X8-C- X2-C-X4-GWXY-X10 -K-X6-E. In the consensus Note sequence, the number of non-consensus residues, Two transcript variants encode two protein designated as X, is identical for all species isoforms differing at their amino-termini.
    [Show full text]
  • Bioinformatics Analysis of the CDK2 Functions in Neuroblastoma
    MOLECULAR MEDICINE REPORTS 17: 3951-3959, 2018 Bioinformatics analysis of the CDK2 functions in neuroblastoma LIJUAN BO1*, BO WEI2*, ZHANFENG WANG2, DALIANG KONG3, ZHENG GAO2 and ZHUANG MIAO2 Departments of 1Infections, 2Neurosurgery and 3Orthopaedics, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China Received December 20, 2016; Accepted November 14, 2017 DOI: 10.3892/mmr.2017.8368 Abstract. The present study aimed to elucidate the poten- childhood cancer mortality (1,2). Despite intensive myeloabla- tial mechanism of cyclin-dependent kinase 2 (CDK2) in tive chemotherapy, survival rates for neuroblastoma have not neuroblastoma progression and to identify the candidate substantively improved; relapse is common and frequently genes associated with neuroblastoma with CDK2 silencing. leads to mortality (3,4). Like most human cancers, this child- The microarray data of GSE16480 were obtained from the hood cancer can be inherited; however, the genetic aetiology gene expression omnibus database. This dataset contained remains to be elucidated (3). Therefore, an improved under- 15 samples: Neuroblastoma cell line IMR32 transfected standing of the genetics and biology of neuroblastoma may with CDK2 shRNA at 0, 8, 24, 48 and 72 h (n=3 per group; contribute to further cancer therapies. total=15). Significant clusters associated with differen- In terms of genetics, neuroblastoma tumors from patients tially expressed genes (DEGs) were identified using fuzzy with aggressive phenotypes often exhibit significant MYCN C-Means algorithm in the Mfuzz package. Gene ontology and proto-oncogene, bHLH transcription factor (MYCN) amplifi- pathway enrichment analysis of DEGs in each cluster were cation and are strongly associated with a poor prognosis (5).
    [Show full text]